Top Sildenafil Brands: A Curated Collection

Sildenafil, commonly known for its brand name Viagra, is a widely used medication for treating erectile dysfunction. Over the years, several reputable pharmaceutical companies have developed their own versions of this popular drug, offering quality and efficacy. Among the leading brands are Pfizer, the original creator of Viagra, as well as Teva and Cipla, which provide trusted generic options. For those interested in exploring a comprehensive list of the best sildenafil brands available, read on below.

Illustration of sildenafil

Best brands of sildenafil in 2025

Viagra

Viagra, produced by Pfizer, remains a dominant force in the erectile dysfunction drugs market, holding a 58% revenue share despite intense generic competition. Introduced in 1998, Viagra has maintained its market presence even after losing patent exclusivity in 2017, with Q3 2020 sales showing a 29% increase over Q2. The drug is available in 25 mg, 50 mg, and 100 mg doses and is recommended to be taken approximately 1 hour before sexual activity. Viagra's resilience is attributed to Pfizer's strategic marketing, brand recognition, and the introduction of an authorized generic version. The drug continues to generate significant revenue, with North America accounting for 51.7% of its market share in 2022.

Revatio

Revatio, produced by Pfizer, is a leading brand for sildenafil, specifically designed for the treatment of pulmonary arterial hypertension (PAH). It is the only FDA-approved phosphodiesterase-5 (PDE-5) inhibitor available in both oral and intravenous formulations, approved by the FDA in June 2005 for oral tablets and in November 2009 for the intravenous injection. Revatio has been recommended by the American College of Chest Physicians for adult PAH patients in functional class II and III, and it is administered as a 20 mg tablet or a 10 mg intravenous bolus injection three times a day. The drug has shown effectiveness in short-term studies, predominantly in patients with idiopathic or connective tissue disease-associated PAH. Revatio's unique formulations and established efficacy make it a significant treatment option in the management of PAH. For more detailed information, please visit the Pfizer Revatio labeling.

Kamagra

Kamagra, produced by Ajanta Pharma, is a highly recognized brand for sildenafil citrate, often marketed as a generic version of Viagra. It is known for its effectiveness in treating erectile dysfunction and pulmonary arterial hypertension by improving blood flow. Ajanta Pharma's Kamagra is available in various forms, including regular, chewable, and effervescent pills, as well as gel formulations. The company has seen significant growth, with a long-term sales CAGR of 23% and a PAT CAGR of 47%, and it plans to expand its market presence, including entry into the US market in the near future.

Suhagra

Suhagra, manufactured by Cipla Ltd., is a highly recognized pharmaceutical product for managing erectile dysfunction, containing the active ingredient sildenafil citrate, a phosphodiesterase type 5 (PDE5) inhibitor. It is available in dosages of 25 mg, 50 mg, and 100 mg, offering flexibility in treatment. Approved by the FDA for treating erectile dysfunction and pulmonary arterial hypertension, Suhagra has a bioavailability of 41% and its effects last up to four hours. The medication is known for its reliability and consistent performance, making it a trusted option in men's health. With its onset of action typically within 30 to 60 minutes, Suhagra is a preferred choice for both patients and healthcare providers. For more detailed information, you can access Suhagra: A Comprehensive Guide.

Fildena

Fildena, produced by Fortune Healthcare, is a highly effective and cost-efficient generic version of Viagra, containing the active ingredient sildenafil citrate. It is chemically identical to Viagra but more affordable, making it a popular choice for treating erectile dysfunction (ED). Fildena is available in various strengths, allowing for customized dosing based on the severity of ED and patient tolerance, with a typical duration of action lasting 4-6 hours. The drug works by inhibiting the enzyme phosphodiesterase type 5 (PDE5), leading to increased blood flow to the penis, and it requires sexual stimulation to be effective. Common side effects are mild and transient, including headaches and dizziness, affecting only about 2% of users.

Cenforce

Cenforce, manufactured by Centurion Laboratories, is a highly effective brand of sildenafil, a phosphodiesterase type 5 (PDE5) inhibitor, used to treat erectile dysfunction in men. It is available in various strengths, including 25mg, 50mg, 100mg, 150mg, and 200mg, allowing for tailored dosages based on individual needs. Cenforce works by increasing blood flow to the penis, facilitating erections during sexual stimulation, and its efficacy is similar to that of Viagra, but often at a lower cost. The medication requires sexual arousal to be effective and is generally well-tolerated, though it may interact with certain medications like nitrates and alpha-blockers. With its high selectivity for PDE5, Cenforce ensures minimal impact on other phosphodiesterases, such as PDE3 involved in cardiac contractility. For more details on this medication, visit the official Cenforce product page.

Vigora

Vigora, produced by German Remedies, is a notable brand in the market for sildenafil, known for its efficacy in treating erectile dysfunction. As a generic version of Viagra, Vigora has gained trust for its reliable performance, with an average onset of action of 20-30 minutes when taken orally. The drug, a PDE 5 inhibitor, has a bioavailability of around 41% and is metabolized primarily by the liver via the CYP3A4 pathway. Vigora's popularity is reflected in the growing erectile dysfunction treatment market, which was valued at USD 3.31 billion in 2023 and is expected to reach USD 5.97 billion by 2032. With its established chemical-pharmaceutical quality and bioequivalence to Viagra, Vigora remains a preferred choice for many patients. For more detailed information, you can visit their official Vigora product page.

Malegra

Malegra, produced by Sunrise Remedies, is a highly regarded generic adaptation of sildenafil citrate, widely used to treat erectile dysfunction. It is ISO 9001:2015 certified, ensuring high-quality manufacturing standards. Malegra starts working within 30-50 minutes, with effects lasting up to 4-5 hours, and it is recommended to take it on an empty stomach for optimal results. The medication is metabolized by the liver, primarily through the CYP3A4 pathway, and it is crucial to follow the recommended dose of one tablet per 24 hours. Malegra is popular globally for its efficacy and affordability. For more information, visit their Malegra product page.

Sildigra

Sildigra, produced by Dharam Distributors, is a highly regarded generic version of sildenafil, offering a cost-effective alternative to brand-name Viagra. It holds a significant share in the erectile dysfunction drugs market, which is expected to grow at a CAGR of 6.8% from 2022 to 2032, with the global market projected to reach USD 6.1 billion by 2032. Generic sildenafil, such as Sildigra, is up to 99% more affordable than name-brand Viagra, making it a preferred option for many. Sildigra starts working within 30-60 minutes and can last up to several hours, similar to other sildenafil products. Its affordability and effectiveness contribute to the dominance of generic sildenafil in the market, with generics accounting for the largest market share due to patent expirations and increasing demand for low-cost alternatives.

Eriacta

Eriacta, produced by Ranbaxy, is a well-known brand of sildenafil, a medication used to treat erectile dysfunction. It works by inhibiting phosphodiesterase type 5 (PDE-5), enhancing the effect of nitric oxide and increasing blood flow to the penis. Eriacta is taken orally and has an onset of action typically within 20 minutes, lasting for about two hours. Common side effects include headaches, heartburn, and flushed skin. Approved for medical use in 1998, sildenafil, the active ingredient in Eriacta, was the 157th most commonly prescribed medication in the United States in 2022, with over 3 million prescriptions. For detailed information on Eriacta's side effects, you can visit their page here.